Calling for @DS to respond, page-36

Testing is expensive and time consuming but that is where ADO has operated since day one.

Unsuccessfully though! Revenue from diagnostics is still negligible. It's been dreaming and wishing and hoping and not enough hard commercial strategy.
Plenty of dilution though.

That is my point!

I am amazed that people still don't get this. ADO tech is only good for new tests, no company wants to repeat the expensive approvals process for a bit of improvement, when the cost to gain regulatory approval is so high.

Nobody cares! Not even Josh Soldo could convince them! That's the point!

It was never viable.

Previous rainbow and unicorn roadshows and strategies did not result in anything material. Until the Chairman's address pre last AGM. That was substantial on batteries, third party testing and on IP changes, in particular to AnteoCoat, Anteobind etc. Oddly enough the company has continued to apply this strategy. Marvellous innit?

As @bourbasted confirms, what matters is the battery space and that's overseas.

This is to raise funds/lift the SP. Surely?
For all these reasons and more I think a consolidation is inevitable.

If not soon, later.